{
    "Trade/Device Name(s)": [
        "VITEK 2 AST-Gram Negative Ceftazidime (\u22640.5 - \u226532 \u03bcg/mL)",
        "VITEK 2 AST-GN Ceftazidime (\u22640.5 - \u226532 \u03bcg/mL)"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K193299",
    "Predicate Device Reference 510(k) Number(s)": [
        "K191766"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTT",
        "LTW"
    ],
    "Summary Letter Date": "September 28, 2020",
    "Summary Letter Received Date": "November 27, 2019",
    "Submission Date": "November 26, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ceftazidime susceptibility (Gram negative bacilli)",
        "Citrobacter species",
        "Enterobacter species",
        "Escherichia coli",
        "Klebsiella species",
        "Proteus mirabilis",
        "Proteus vulgaris",
        "Pseudomonas aeruginosa",
        "Serratia species",
        "Acinetobacter species",
        "Citrobacter koseri",
        "Citrobacter freundii",
        "Providencia species",
        "Salmonella species",
        "Shigella species",
        "Yersinia enterocolitica"
    ],
    "Specimen Type(s)": [
        "Isolates of aerobic Gram-negative bacilli"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative antimicrobial susceptibility testing",
        "Microdilution minimum inhibitory concentration (MIC)"
    ],
    "Methodologies": [
        "Growth Pattern Analysis",
        "Broth microdilution reference method"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Panel",
        "Automated system"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-Gram Negative Ceftazidime susceptibility card using automated MIC technology on VITEK 2 platforms.",
    "Indications for Use Summary": "For antimicrobial susceptibility testing of Gram negative bacilli with VITEK 2 and VITEK 2 Compact Systems to aid in in vitro susceptibility determination to antimicrobial agents.",
    "fda_folder": "Microbiology"
}